Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-026228
Filing Date
2021-06-28
Accepted
2021-06-28 17:16:40
Documents
1
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6380
  Complete submission text file 0000899243-21-026228.txt   7873
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Issuer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Dananberg Jamie (Reporting) CIK: 0001734424 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38470 | Film No.: 211054504